Inlexisertib;DCC-3116

Non Chimik:

4-(3-((2-((2-etil-4-(4-methylpiperazin-1-yl)phenyl)amino)-5-(trifluorometil)pirimidin-4-yl)amino)propil)-1,4 -oxazepan-5-yonn

Kòd SMILES:

O=C1CCOCCN1CCCNC2=NC(NC3=C(CC)C=C(N4CCN(C)CC4)C=C3)=NC=C2C(F)(F)F

Kòd InChi:

InChI=1S/C26H36F3N7O2/c1-3-19-17-20(35-12-10-34(2)11-13-35)5-6-22(19)32-25-31-18-21( 26(27,28 )29)24(33-25)30-8-4-9-36-14-16-38-15-7-23(36)37/h5-6,17-18H,3-4,7-16H2 ,1-2H3,(H2,30,31,32,33)

InChi kle:

CNBTYICEJGEABG-UHFFFAOYSA-N

Mot:

2543673-19-2；CAS:2543673-19-2；CAS:2543673-19-2；DCC3116；DCC-3116；DCC 3116；Inlexisertib

Solibilite: 

Depo:Sèk, nwa ak nan 0 -4 C pou kout tèm (jou a semèn) oswa -20 C pou tèm long (mwa a ane).

Deskripsyon:

DCC-3116 se yon inibitè ULK1/2 aktif oralman.

Sib: ULK1/2